News

High-risk stage III-IV melanoma patients treated with pembrolizumab report better quality of life

0
Professional, doctor. Scientist with microscope

Patients with high-risk stage III-IV melanoma who received pembrolizumab after their surgery reported a better quality of life than patients who received the previous standard-of-care treatment with either ipilimumab or high-dose interferon.

Study shows link between vaping and risk of caries

Previous article

The best Black Friday Beats deals live in the UK

Next article

You may also like

Comments

Leave a reply

Your email address will not be published. Required fields are marked *

More in News